# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA836246 | B | In vitro inhibitory activity against PTP1B at 100 uM 10 min incubation | Mus musculus | 23 | single protein format | Scientific Literature | ||
2. | ALA830627 | B | Percentage inhibition (100 uM) against protein tyrosine phosphate | 11 | assay format | Scientific Literature | |||
3. | ALA918281 | B | Inhibition of PTP1B at 100 uM | 27 | single protein format | Scientific Literature | |||
4. | ALA976167 | B | Inhibition of PTP1B at 100 uM | 19 | single protein format | Scientific Literature | |||
5. | ALA1109326 | B | Inhibition of PTP1B at 100 uM | 20 | single protein format | Scientific Literature | |||
6. | ALA1169054 | B | Inhibition of DPP4 at 100 uM after 15 mins by spectrofluorimeter | 33 | single protein format | Scientific Literature | |||
7. | ALA1635808 | B | Inhibition of recombinant PTP1B expressed in Escherichia coli BL21 up to 5 ug/ml after 30 mins by spectrophotometry | 36 | assay format | Scientific Literature | |||
8. | ALA1635809 | B | Inhibition of recombinant PTP1B expressed in Escherichia coli BL21 after 30 mins by spectrophotometry | 36 | assay format | Scientific Literature | |||
9. | ALA1909163 | B | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | tissue-based format | DrugMatrix | ||
10. | ALA1909164 | B | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | cell membrane format | DrugMatrix | |||
11. | ALA1909165 | B | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | tissue-based format | DrugMatrix | ||
12. | ALA1909166 | B | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
13. | ALA1909167 | B | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
14. | ALA1909168 | B | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
15. | ALA1909169 | B | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | 871 | cell-based format | DrugMatrix | |||
16. | ALA1909170 | B | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
17. | ALA1909171 | B | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
18. | ALA1909172 | B | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
19. | ALA1909173 | B | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
20. | ALA1909174 | B | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix |